REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/28/2025
Back to search
Official data from USPTO
DIAGNOSTICS DEFINING THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DIAGNOSTICS DEFINING THERAPY
ST13
US500000079259148Class
1, 5, 10, 42, 44
Filing
79259148
Registration
6039262
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/29/2025
Trademark type
Word
Nice classes
1, 5, 10, 42, 44
Filing date
12/21/2018
Registration date
04/28/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2020
Last transaction
04/29/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
AU
Examiner
BUSH, KAREN
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
SpeeDx Pty Ltd
Representatives
Joi A. White Carr & Ferrell LLP
Technical classification
Nice Classes
Class 1Class 5Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals used in industrysciencephotographyagriculturehorticulture and forestryexcept fungicidesherbicidesinsecticidesparasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acidsnamely inorganic acids for industrial purposes; DNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
Class 5
Pharmaceutical and veterinary preparations and substances; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy; chemical preparations containing enzymes for pharmaceuticalveterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy; enzymes for pharmaceuticalveterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseasesfor detection and identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppression and immune disordersfor genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and analysis of epigenetic alterationsfor analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expressionprotein expressionmetabolite expressioninflammationimmune-suppressionimmune disorders
Class 10
Surgicalmedical and veterinary apparatus and instruments; diagnostic testing apparatus and instruments for medical purposes; diagnostic testing kits containing diagnostic testing apparatus; point of care medical devices; screening kits in this class comprised of medical screening and testing apparatus for the diagnosis of diseasedetection and/or identification of pathogensfor the detection of antibiotic resistancefor the analysis of gene expressionprotein expressionmetabolic expressioninflammationimmune-suppression and/or immune disorders for genotypinganalysis of polymorphismsdetection of acquired or inherited genetic mutationsdetection and/or analysis of epigenetic alterationsanalysis of response to therapy
Class 42
Scientific and technological services and research and design relating theretoDNA analysis services for scientific research purposesscientific research consulting in the field of genetics; genetic research; genetic engineering services; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry serviceschemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of diagnostic apparatus for genetics research; design of diagnostic apparatus for genetics research; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biologicalbacteriologicalchemicalbiochemicaldnarnaproteinpolynucleic acid and molecular analysis and evaluation services; dna and rna and polynucleic acid and protein sequencinganalysis and evaluation services; genome sequencing services and the analysis and evaluation of data resulting therefrom; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experimentsthe results of scientific and medical experiments and teststhe analysis and evaluation of scientific and medical datadata generated by scientific and medical experiments and tests; scientific and medical research and development services; custom design and development of biochemical assays; molecular diagnostics testing
Class 44
Medical services; human healthcare services; medical testing services relating to the diagnosis and treatment of disease; genetic testing for medical purposes; medical and health services relating to dnagenetics and genetic testing; medical diagnostic services in the nature of medical testing and medical analysis; providing collected and analysed medical information in the field of genetic and treatment information for diseases and disorders for diagnostic and treatment purposes; diagnostic imaging for medical purposes and molecular medicine healthcare services
Publications
History of USPTO decisions and trademark events.
31 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/08/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/13/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/06/2020
FIMP
FINAL DISPOSITION PROCESSED
08/31/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2020
GPNX
NOTIFICATION PROCESSED BY IB
02/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/11/2020
PUBO
PUBLISHED FOR OPPOSITION
02/11/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/29/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/29/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/22/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/07/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/19/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/18/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/17/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/17/2019
RFNT
REFUSAL PROCESSED BY IB
07/12/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/24/2019
RFRR
REFUSAL PROCESSED BY MPU
06/24/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/05/2019
CNRT
NON-FINAL ACTION WRITTEN
06/04/2019
MAFR
APPLICATION FILING RECEIPT MAILED
06/01/2019
DOCK
ASSIGNED TO EXAMINER
05/28/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/28/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/23/2019
Continuous trademark protection
Get notified about every new filing that threatens DIAGNOSTICS DEFINING THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.